Page 7 - Pfizer

Pfizer-BioNTech ask EU agency to approve vaccine for kids 5-11

Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union

Pfizer asks US govt to allow Covid vaccine shots for kids ages 5 to 11

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today's age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities. Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration. Now the FDA will have to decide if there's enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26. One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second .

Pfizer vaccine effective against Covid hospitalisations for 6 months: Study

The study was published in The Lancet journal on Tuesday

Covid-19 pandemic: EU panel backs booster shots of Pfizer, Moderna

Those ages 18 and older can get a third dose of the Pfizer vaccine, developed with BioNTech SE, at least six months after their second shot, the European Medicines Agency said in a statement Monday

Pfizer to sell Upjohn business to Mylan Pharma for Rs 180.48 crore

The transaction in India will be closed upon receipt of regulatory approvals, Pfizer Ltd said

2 doses of Pfizer vax may protect kids from long Covid: Study

The US Food and Drug Administration (FDA) has approved two doses of Pfizer-BioNTech Covid-19 vaccine to be administered to children ages 12 through 15, 21 days apart.

Pfizer Covid-19 vaccine for kids may not be available until November

Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November

Biden touts Pfizer booster access after CDC boss overrules panel

The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement advising that booster shots could be given to people with the Pfizer vaccine 6 months after second shot

US FDA okays Covid booster shot for people above 65, or at high-risk

The US Food and Drug Administration (FDA) has authorised booster shots of the Pfizer Covid-19 vaccine for people aged 65 and older or at high-risk

US CDC panel endorses Pfizer booster shot for elderly, high-risk people

A US CDC advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions

EU regulator to decide on Pfizer booster dose at the start of October

Pfizer declined to comment, while BioNTech was not available for comment

US approves third Pfizer dose for people above 65, at-risk Americans

The panel is likely to discuss guidance for physicians on how to administer the third doses

FDA approves older, Covid at-risk people for Pfizer booster shot in US

Booster doses can be given any time at least six months after a person received their second shot, says the agency.

Joe Biden doubles US global donation of Pfizer Covid-19 vaccine shots

President Joe Biden announced Wednesday that the United States is doubling its purchase of Pfizer's Covid-19 shots to share with the world to 1 billion doses

India unlikely to buy Pfizer, Moderna Covid-19 vaccines for now: Sources

India is unlikely to buy Pfizer and Moderna Covid-19 vaccines for now as the domestic manufacturing of anti-coronavirus jabs has picked up pace, sources said

Pfizer Covid-19 vaccine safely bolsters antibodies in younger kids

Drugmaker, partner BioNTech to submit data to US regulators

Top headlines: Evergrande threat hits markets; Pfizer vaccine works on kids

Business Standard brings you the top headlines on Monday

Pfizer vaccine safe for children aged 5-11, show clinical trial results

Pfizer said Monday its Covid-19 vaccine works for children ages 5 to 11 and that it will seek US authorisation for this age group soon -- a key step toward beginning vaccinations for youngsters.

US FDA panel backs booster shot for elderly, high risk groups

A US FDA advisory panel has endorsed a booster shot of Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease

FDA advisory panel rejects widespread Pfizer booster shots

An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against Covid-19 to most Americans.